Biblio

Author Title [ Type(Asc)] Year
Filters: Author is Barker, Roger A  [Clear All Filters]
Journal Article
Stott S, Broza YY, Gharra A, Wang Z, Barker RA, Haick H. The Utility of Breath Analysis in the Diagnosis and Staging of Parkinson's Disease. J Parkinsons Dis. 2022.
Wyse RK, Isaacs T, Barker RA, Cookson MR, Dawson TM, Devos D, Dexter DT, Duffen J, Federoff H, Fiske B, et al. Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson's Disease: The International Linked Clinical Trials initiative. J Parkinsons Dis. 2024.
Sugarman J, Barker RA, Kerridge I, Lysaght T, Pellegrini G, Sipp D, Tanner C. Tackling Ethical Challenges of Premature Delivery of Stem Cell-Based Therapies: ISSCR 2018 Annual Meeting Focus Session Report. Stem Cell Reports. 2018;11(5):1021-1025.
Drouin-Ouellet J, Barker RA. Stem cell therapies for Parkinson's disease: are trials just around the corner?. Regen Med. 2014;9(5):553-555.
Owen NE, Barker RA, Voysey ZJ. Sleep Dysfunction in Huntington's Disease: Impacts of current medications and prospects for treatment. J Huntingtons Dis. 2023.
Fazal SV, Mutschler C, Chen CZ, Turmaine M, Chen C-Y, Hsueh Y-P, Ibañez-Grau A, Loreto A, Casillas-Bajo A, Cabedo H, et al. SARM1 detection in myelinating glia: / is dispensable for PNS and CNS myelination in zebrafish and mice. Front Cell Neurosci. 2023;17:1158388.
Barker RA, Björklund A. Restorative cell and gene therapies for Parkinson's disease. Handb Clin Neurol. 2023;193:211-226.
Harris KL, Mason SL, Vallin B, Barker RA. Reduced expression of dopamine D2 receptors on astrocytes in R6/1 HD mice and HD post-mortem tissue. Neurosci Lett. 2021:136289.
Wijeyekoon RS, Kronenberg-Versteeg D, Scott KM, Hayat S, Kuan W-L, Evans JR, Breen DP, Cummins G, Jones JL, Clatworthy MR, et al. Peripheral innate immune and bacterial signals relate to clinical heterogeneity in Parkinson's disease. Brain Behav Immun. 2020.
Barker RA, Boer GJ, Cattaneo E, R Charo A, Lopes SMChuva de, Cong Y, Fujita M, Goldman S, Hermerén G, Hyun I, et al. The need for a standard for informed consent for collection of human fetal material. Stem Cell Reports. 2022;17(6):1245-1247.
Bulstrode H, Girdler GC, Gracia T, Aivazidis A, Moutsopoulos I, Young AMH, Hancock J, He X, Ridley K, Xu Z, et al. Myeloid cell interferon secretion restricts Zika flavivirus infection of developing and malignant human neural progenitor cells. Neuron. 2022.
Onorati M, Castiglioni V, Biasci D, Cesana E, Menon R, Vuono R, Talpo F, Goya RLaguna, Lyons PA, Bulfamante GP, et al. Molecular and functional definition of the developing human striatum. Nat Neurosci. 2014.
Hannaway N, Lao-Kaim NP, Martín-Bastida A, Roussakis A-A, Howard J, Wall MB, Loane C, Barker RA, Piccini P. Longitudinal changes in movement-related functional MRI activity in Parkinson's disease patients. Parkinsonism Relat Disord. 2021;87:61-69.
Ye R, Hezemans FH, O'Callaghan C, Tsvetanov KA, Rua C, P Jones S, Holland N, Malpetti M, Murley AG, Barker RA, et al. Locus coeruleus integrity is linked to response inhibition deficits in Parkinson's disease and progressive supranuclear palsy. J Neurosci. 2023.
Garza R, Atacho DAM, Adami A, Gerdes P, Vinod M, Hsieh PH, Karlsson O, Horvath V, Johansson PA, Pandiloski N, et al. LINE-1 retrotransposons drive human neuronal transcriptome complexity and functional diversification. Sci Adv. 2023;9(44):eadh9543.
Lovell-Badge R, Anthony E, Barker RA, Bubela T, Brivanlou AH, Carpenter M, R Charo A, Clark A, Clayton E, Cong Y, et al. ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update. Stem Cell Reports. 2021.
Stoker TB, Andresen KER, Barker RA. Hydrocephalus Complicating Intrathecal Antisense Oligonucleotide Therapy for Huntington's Disease. Mov Disord. 2020.
Harris KL, Armstrong M, Swain R, Erzinclioglu S, Das T, Burgess N, Barker RA, Mason SL. Huntington's disease patients display progressive deficits in hippocampal-dependent cognition during a task of spatial memory. Cortex. 2019;119:417-427.
Barker RA, Fujimaki M, Rogers P, Rubinsztein DC. Huntingtin-lowering strategies for Huntington's disease. Expert Opin Investig Drugs. 2020.
Pircs K, Petri R, Madsen S, Brattås PLudvik, Vuono R, Ottosson DR, St-Amour I, Hersbach BA, Matusiak-Brückner M, Lundh SHult, et al. Huntingtin Aggregation Impairs Autophagy, Leading to Argonaute-2 Accumulation and Global MicroRNA Dysregulation. Cell Rep. 2018;24(6):1397-1406.
Pircs K, Barker RA, Jakobsson J. Hunting Out the autophagic problem in Huntington disease. Autophagy. 2022.
Zhang B, He P, Lawrence JEG, Wang S, Tuck E, Williams BA, Roberts K, Kleshchevnikov, ii V, Mamanova L, Bolt L, et al. A human embryonic limb cell atlas resolved in space and time. Nature. 2023.
Walsh RM, Luongo R, Giacomelli E, Ciceri G, Rittenhouse C, Verrillo A, Galimberti M, Bocchi VDickinson, Wu Y, Xu N, et al. Generation of human cerebral organoids with a structured outer subventricular zone. Cell Rep. 2024;43(4):114031.
Kane PBodilly, Benjamin DM, Barker RA, Lang AE, Sherer T, Kimmelman J. Forecasts for the Attainment of Major Research Milestones in Parkinson's Disease. J Parkinsons Dis. 2020.
Stoker TB, Holden ST, Barker RA. Correction to: Late‑onset Huntington's disease associated with CAG repeat lengths of 30 and 31. J Neurol. 2021.

Pages